25T2-NBOMe

A synthetic psychedelic compound

25T2-NBOMe, also known as 2C-T-2-NBOMe, is a synthetic psychedelic compound belonging to the NBOMe series. It is a derivative of the phenethylamine psychedelic 2C-T-2 and is known for its potent hallucinogenic effects.

Chemical Structure and Properties

25T2-NBOMe is a member of the NBOMe class of compounds, which are characterized by the presence of a 2-methoxybenzyl group attached to the nitrogen atom of the phenethylamine backbone. This modification significantly increases the compound's affinity for the 5-HT2A receptor, which is primarily responsible for its psychedelic effects.

The chemical structure of 25T2-NBOMe is similar to that of other NBOMe compounds, such as 25I-NBOMe and 25C-NBOMe, but it features a thioether group in the 2-position of the phenethylamine core, which is derived from the parent compound 2C-T-2.

Pharmacology

25T2-NBOMe acts as a potent agonist at the 5-HT2A receptor, which is a subtype of the serotonin receptor family. Activation of this receptor is known to produce psychedelic effects, including altered perception, mood, and cognition. The compound's high affinity for the 5-HT2A receptor makes it active at very low doses, often in the microgram range.

Effects

The effects of 25T2-NBOMe are similar to those of other psychedelics, such as LSD and psilocybin. Users report visual hallucinations, changes in thought patterns, and an altered sense of time. However, due to its potency, the effects can be unpredictable and may include negative experiences such as anxiety, paranoia, and confusion.

Risks and Safety

25T2-NBOMe is considered to be a research chemical, and its safety profile is not well-established. There have been reports of severe adverse effects, including vasoconstriction, seizures, and cardiac arrest, particularly at higher doses. As with other NBOMe compounds, there is a risk of overdose due to the compound's potency and the difficulty in measuring accurate doses.

Legal Status

The legal status of 25T2-NBOMe varies by country. In some jurisdictions, it is classified as a controlled substance, while in others, it remains unscheduled. Users should be aware of the legal implications of possessing or distributing this compound in their region.

Also see

• NBOMe series
• 2C-T-2
• Psychedelic drug
• 5-HT2A receptor

Receptor Ligands
'
Class	Not specified
Function	Not specified
Endogenous Ligands	None listed
Agonists	None listed
Antagonists	None listed
Partial Agonists	None listed
Inverse Agonists	None listed
Allosteric Modulators	None listed
Related Receptors	None listed